These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

693 related articles for article (PubMed ID: 35377983)

  • 1. Comprehensive Analysis of N6-Methyladenosine-Related IncRNAs Prognostic Signature and the Associated Immune Infiltrates in Kidney Renal Clear Cell Carcinoma.
    Chen X; Wang L; Tu J; Pan X; Li Y; Yin H; Wang M; Yuan X
    Crit Rev Eukaryot Gene Expr; 2022; 32(1):79-98. PubMed ID: 35377983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell Carcinoma.
    Yu J; Mao W; Sun S; Hu Q; Wang C; Xu Z; Liu R; Chen S; Xu B; Chen M
    Front Oncol; 2021; 11():663263. PubMed ID: 34123820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hub Long Noncoding RNAs with m6A Modification for Signatures and Prognostic Values in Kidney Renal Clear Cell Carcinoma.
    Lin G; Wang H; Wu Y; Wang K; Li G
    Front Mol Biosci; 2021; 8():682471. PubMed ID: 34295922
    [No Abstract]   [Full Text] [Related]  

  • 4. Integrated analysis on the N6-methyladenosine-related long noncoding RNAs prognostic signature, immune checkpoints, and immune cell infiltration in clear cell renal cell carcinoma.
    Qiu Y; Wang X; Fan Z; Zhan S; Jiang X; Huang J
    Immun Inflamm Dis; 2021 Dec; 9(4):1596-1612. PubMed ID: 34432955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancer.
    Ma T; Wang X; Meng L; Liu X; Wang J; Zhang W; Tian Z; Zhang Y
    BMC Cancer; 2021 Nov; 21(1):1256. PubMed ID: 34802433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical significance, immune infiltration, and tumor mutational burden of angiogenesis-associated lncRNAs in kidney renal clear cell carcinoma.
    Zhang W; Liu Z; Wang J; Geng B; Hou W; Zhao E; Li X
    Front Immunol; 2022; 13():934387. PubMed ID: 35958561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients.
    Song W; Ren J; Yuan W; Xiang R; Ge Y; Fu T
    Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N6-methyladenosine-related lncRNAs identified as potential biomarkers for predicting the overall survival of Asian gastric cancer patients.
    Xu S; Chen W; Wang Y; Zhang Y; Xia R; Shen J; Gong X; Liang Y; Xu J; Tang H; Zhao T; Zhang Y; Chen T; Wang C
    BMC Cancer; 2022 Jul; 22(1):721. PubMed ID: 35778697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of N6-methyladenosine-related lncRNAs in the tumor immune microenvironment and their prognostic role in pancreatic cancer.
    Liu Y; Wang T; Fang Z; Kong J; Liu J
    J Cancer Res Clin Oncol; 2022 Jul; 148(7):1613-1626. PubMed ID: 35314871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of M7G-related lncRNAs in kidney renal clear cell carcinoma and their putative diagnostic and prognostic role.
    Zhong S; Chen S; Lin H; Luo Y; He J
    BMC Urol; 2023 Nov; 23(1):186. PubMed ID: 37968670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune associated LncRNAs identify novel prognostic subtypes of renal clear cell carcinoma.
    Khadirnaikar S; Kumar P; Pandi SN; Malik R; Dhanasekaran SM; Shukla SK
    Mol Carcinog; 2019 Apr; 58(4):544-553. PubMed ID: 30520148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma.
    Yang K; Wang F; Li K; Peng G; Yang H; Xu H; Xiang Y; Sun H
    Technol Cancer Res Treat; 2022; 21():15330338221085354. PubMed ID: 35422168
    [No Abstract]   [Full Text] [Related]  

  • 13. Expression Profile Analysis of m6A RNA Methylation Regulators Indicates They Are Immune Signature Associated and Can Predict Survival in Kidney Renal Cell Carcinoma.
    Fang J; Hu M; Sun Y; Zhou S; Li H
    DNA Cell Biol; 2020 Oct; ():. PubMed ID: 33085515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological and Prognostic Value of Necroptosis-Associated lncRNA Model in Patients with Kidney Renal Clear Cell Carcinoma.
    Gu J; He Z; Huang Y; Luan T; Chen Z; Wang J; Ding M
    Dis Markers; 2022; 2022():5204831. PubMed ID: 35664432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma.
    Zhao J; Lin X; Zhuang J; He F
    Front Genet; 2021; 12():714697. PubMed ID: 34777460
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of Ferroptosis-Related LncRNAs Signatures Associated with Tumor Immune Infiltration and Experimental Validation in Clear Cell Renal Cell Carcinoma.
    Chen X; Tu J; Ma L; Huang Y; Yang C; Yuan X
    Int J Gen Med; 2022; 15():3215-3235. PubMed ID: 35342303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of N6-Methyladenosine-Related lncRNAs in Early-Stage Colorectal Cancer: Association With Immune Cell Infiltration and Chemotherapeutic Drug Sensitivity.
    Xiong Z; Li X; Yin S; Xie M; Mao C; Zhang F; Chen H; Jin L; Lian L
    Front Mol Biosci; 2021; 8():724889. PubMed ID: 34712696
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer.
    Song Y; Qu H
    BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Critical N6-Methyladenosine-Related Long Non-Coding RNAs and Their Correlations with Immune Checkpoints in Renal Clear Cell Carcinoma.
    Deng W; Wang G; Deng H; Yan Y; Zhu K; Chen R; Liu X; Chen L; Zeng T; Fu B
    Int J Gen Med; 2021; 14():9773-9787. PubMed ID: 34934351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N6-Methyladenosine-Related Long Non-coding RNA Signature Associated With Prognosis and Immunotherapeutic Efficacy of Clear-Cell Renal Cell Carcinoma.
    Ma T; Wang X; Wang J; Liu X; Lai S; Zhang W; Meng L; Tian Z; Zhang Y
    Front Genet; 2021; 12():726369. PubMed ID: 34721523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.